AstraZeneca COVID-19 vaccine COVID-19 vaccines Main navigation COVID-19 vaccines Pfizer bivalent COVID-19 vaccine Moderna bivalent COVID-19 vaccine Pfizer COVID-19 vaccine adult formulation Pfizer COVID-19 vaccine paediatric formulation (5-11 years) Moderna COVID-19 vaccine Novavax COVID-19 vaccine AstraZeneca COVID-19 vaccine All participants Aboriginal and Torres Strait Islander participants Adolescent participants People affected by cancer and transplant recipients Influenza vaccines National Immunisation Program Schedule vaccines Mpox (monkeypox) vaccine As part of the Australian COVID-19 vaccination program, AusVaxSafety is actively monitoring COVID-19 vaccines currently in use in Australia to ensure their ongoing safety. Vaccine safety surveillance through AusVaxSafety occurs in selected vaccination clinics around Australia, including state vaccination hubs, pharmacies, GPs and Aboriginal Community Controlled Health Organisations. Click on the tiles below to view AusVaxSafety COVID-19 vaccine safety data for individuals who received the AstraZeneca COVID-19 vaccine. AstraZeneca COVID-19 vaccine safety data - All participants View the latest safety data here AstraZeneca COVID-19 vaccine safety data - Aboriginal and Torres Strait Islander participants View the latest safety data here AstraZeneca COVID-19 vaccine safety data - adolescent participants View the latest vaccine safety data here AstraZeneca COVID-19 vaccine safety data - People affected by cancer and transplant recipients View the latest vaccine safety data here COVID-19 vaccines Main navigation COVID-19 vaccines Pfizer bivalent COVID-19 vaccine Moderna bivalent COVID-19 vaccine Pfizer COVID-19 vaccine adult formulation Pfizer COVID-19 vaccine paediatric formulation (5-11 years) Moderna COVID-19 vaccine Novavax COVID-19 vaccine AstraZeneca COVID-19 vaccine All participants Aboriginal and Torres Strait Islander participants Adolescent participants People affected by cancer and transplant recipients Influenza vaccines National Immunisation Program Schedule vaccines Mpox (monkeypox) vaccine News & events All news & events 14 September 2023 | News Vaxtracker wins Hunter New England Health Excellence Award 17 May 2023 | News Subcutaneous and intradermal administration of mpox vaccine well tolerated, AusVaxSafety study finds 10 May 2023 | News New bivalent BA.4/BA.5 COVID-19 booster vaccines well tolerated by Australians, new AusVaxSafety data show 20 April 2023 | News Influenza is back in Australia in 2023: Why a flu shot is so important, who is eligible and what to expect in the days following your vaccination